Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 231

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Modulation of hypoxia-signaling pathways by extracellular long non-coding RNA regulator of reprogramming

Open access
Takahashi, Kenji, Yan, Irene K., Haga, Hiroaki, Patel, Tushar·2014·Journal of Cell Science

Abstract

Resistance to adverse environmental conditions such as hypoxia contributes to the efficacy of anticancer therapies and tumor progression. Although deregulated expression of many long non-coding RNA (lncRNA) occur in human cancers, their contributions to tumor responses to hypoxia are unknown. RNA expression profiling identified several hypoxia-responsive lncRNAs including linc-RoR, which is also increased in expression in malignant liver cancer cells. Linc-RoR expression was increased in hypoxic regions within tumor cell xenografts in vivo. Tumor cell viability during hypoxia was reduced by siRNA to linc-RoR. Compared to controls, siRNA to linc-RoR decreased p70S6K1 phosphorylation, PDK1 and HIF-1α protein expression, and increased expression of the linc-RoR target miR-145. Linc-RoR was highly expressed in extracellular RNA released by HCC cells during hypoxia. Incubation with extracellular vesicle preparations containing extracellular RNA increased linc-RoR, HIF-1α expression and cell survival in recipient cells. These studies show that lncRNA-RoR is a hypoxia-responsive lncRNA that is functionally linked to hypoxia signaling in HCC through a miR-145/HIF-1α signaling module, and identify a mechanistic role of inter-cellular extracellular transfer of linc-RoR in promoting cell survival during hypoxic stress.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1242/jcs.141069

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 29

  1. Ariel, 1998, Imprinted H19 oncofetal RNA is a candidate tumour marker for hepatocellular carcinoma., Mol. Pathol., 51, 21, 10.1136/mp.51.1.21 · DOI
  2. Batagov, 2011, Identification of nucleotide patterns enriched in secreted RNAs as putative cis-acting elements targeting them to exosome nano-vesicles., BMC Genomics, 12, S18, 10.1186/1471--2164--12--S3--S18 · doi:10.1186/1471--2164--12--s3--s18
  3. Boyer, 2006, Polycomb complexes repress developmental regulators in murine embryonic stem cells., Nature, 441, 349, 10.1038/nature04733 · DOI · Paper page
  4. Braconi, 2011, Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma., Proc. Natl. Acad. Sci. USA, 108, 786, 10.1073/pnas.1011098108 · DOI · Paper page
  5. Braconi, 2011, microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer., Oncogene, 30, 4750, 10.1038/onc.2011.193 · DOI · Paper page
  6. El-Serag, 2012, Epidemiology of viral hepatitis and hepatocellular carcinoma., Gastroenterology, 142, 1264, 10.1053/j.gastro.2011.12.061 · DOI · Paper page
  7. Gadaleta, 2011, Trans-arterial chemoembolization as a therapy for liver tumours: New clinical developments and suggestions for combination with angiogenesis inhibitors., Crit. Rev. Oncol. Hematol., 80, 40, 10.1016/j.critrevonc.2010.10.005 · DOI
  8. Kogure, 2011, Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth., Hepatology, 54, 1237, 10.1002/hep.24504 · DOI · Paper page
  9. Kong, 2012, Insufficient radiofrequency ablation promotes angiogenesis of residual hepatocellular carcinoma via HIF-1α/VEGFA., PLoS ONE, 7, e37266, 10.1371/journal.pone.0037266 · DOI
  10. Lai, 2012, Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation., Med. Oncol., 29, 1810, 10.1007/s12032--011--0004--z · doi:10.1007/s12032--011--0004--z
  11. Lee, 2006, Control of developmental regulators by Polycomb in human embryonic stem cells., Cell, 125, 301, 10.1016/j.cell.2006.02.043 · DOI · Paper page
  12. Loewer, 2010, Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells., Nat. Genet., 42, 1113, 10.1038/ng.710 · DOI · Paper page
  13. Nagano, 2008, The Air noncoding RNA epigenetically silences transcription by targeting G9a to chromatin., Science, 322, 1717, 10.1126/science.1163802 · DOI · Paper page
  14. Nath, 2012, Hypoxia and hypoxia inducible factors: diverse roles in liver diseases., Hepatology, 55, 622, 10.1002/hep.25497 · DOI · Paper page
  15. Panzitt, 2007, Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA., Gastroenterology, 132, 330, 10.1053/j.gastro.2006.08.026 · DOI · Paper page
  16. Papandreou, 2006, HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption., Cell Metab., 3, 187, 10.1016/j.cmet.2006.01.012 · DOI · Paper page
  17. Rinn, 2007, Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs., Cell, 129, 1311, 10.1016/j.cell.2007.05.022 · DOI · Paper page
  18. Saunderson, 2008, Induction of exosome release in primary B cells stimulated via CD40 and the IL-4 receptor., J. Immunol., 180, 8146, 10.4049/jimmunol.180.12.8146 · DOI
  19. Shim, 2008, Association between increment of serum VEGF level and prognosis after transcatheter arterial chemoembolization in hepatocellular carcinoma patients., Cancer Sci., 99, 2037, 10.1111/j.1349-7006.2008.00909.x · DOI · Paper page
  20. Skog, 2008, Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers., Nat. Cell Biol., 10, 1470, 10.1038/ncb1800 · DOI · Paper page
  21. Théry, 2009, Membrane vesicles as conveyors of immune responses., Nat. Rev. Immunol., 9, 581, 10.1038/nri2567 · DOI · Paper page
  22. Tripathi, 2010, The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation., Mol. Cell, 39, 925, 10.1016/j.molcel.2010.08.011 · DOI · Paper page
  23. Valadi, 2007, Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells., Nat. Cell Biol., 9, 654, 10.1038/ncb1596 · DOI · Paper page
  24. Wang, 2013, Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal., Dev. Cell, 25, 69, 10.1016/j.devcel.2013.03.002 · DOI · Paper page
  25. Whittaker, 2010, The role of signaling pathways in the development and treatment of hepatocellular carcinoma., Oncogene, 29, 4989, 10.1038/onc.2010.236 · DOI · Paper page
  26. Xiang, 2011, Gene expression profiling of fixed tissues identified hypoxia-inducible factor-1α, VEGF, and matrix metalloproteinase-2 as biomarkers of lymph node metastasis in hepatocellular carcinoma., Clin. Cancer Res., 17, 5463, 10.1158/1078--0432.CCR--10--3096 · doi:10.1158/1078--0432.ccr--10--3096
  27. Xu, 2012, MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis., Nucleic Acids Res., 40, 761, 10.1093/nar/gkr730 · DOI · Paper page
  28. Zhao, 2008, Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome., Science, 322, 750, 10.1126/science.1163045 · DOI · Paper page
  29. Zheng, 2013, Prognostic significance of HIF-1α expression in hepatocellular carcinoma: a meta-analysis., PLoS ONE, 8, e65753, 10.1371/journal.pone.0065753 · DOI

Cited by

See all 231

Metadata

Authors
Takahashi, K., Yan, I. K., Haga, H., & Patel, T.
Venue
Journal of Cell Science
Published
2014-01-01
Volume
127
Issue
Pt 7
Pages
1585-94
ISSN
  • 0021-9533 (ISSN-L)
  • 1477-9137
OpenAlex
W2158937157
Cited by
231
References
3
FWCI
8.65
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.